MYC and neoplasm: The Western blotting analysis of proliferation of the expression of biomarkers in tumor tissues showed that the miR-935 mimic treatment suppressed the β-catenin, cyclin-D1, c-myc, and PCNA (*p < 0.05 when compared with the miR-NC group, Figures 4G,H).